Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 064132/0202 | |
| Pages: | 8 |
| | Recorded: | 06/30/2023 | | |
| Attorney Dkt #: | 4001-002 |
| Conveyance: | NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2019
|
Application #:
|
16038729
|
Filing Dt:
|
07/18/2018
|
|
Publication #:
|
|
Pub Dt:
|
01/10/2019
| | | | |
|
Title:
|
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/29/2021
|
Application #:
|
16551198
|
Filing Dt:
|
08/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/12/2019
| | | | |
|
Title:
|
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/19/2024
|
Application #:
|
17110558
|
Filing Dt:
|
12/03/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2021
| | | | |
|
Title:
|
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/09/2024
|
Application #:
|
17143280
|
Filing Dt:
|
01/07/2021
|
|
Publication #:
|
|
Pub Dt:
|
09/16/2021
| | | | |
|
Title:
|
USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
|
|
|
Assignee
|
|
|
|
|
| FORUM 1, NOVARTIS CAMPUS |
| BASEL, SWITZERLAND 4056 |
|
|
Correspondence name and address
|
| |
THE MARBURY LAW GROUP, PLLC
|
| |
11800 SUNRISE VALLEY DRIVE
|
| |
15TH FLOOR
|
| |
RESTON, VA 20191
|
Search Results as of:
05/30/2024 01:17 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
